Author:
Powell Gregory E.,Seifert Harry A.,Reblin Tjark,Burstein Phil J.,Blowers James,Menius J. Alan,Painter Jeffery L.,Thomas Michele,Pierce Carrie E.,Rodriguez Harold W.,Brownstein John S.,Freifeld Clark C.,Bell Heidi G.,Dasgupta Nabarun
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference54 articles.
1. World Health Organization. The importance of PV: safety monitoring of medical products. World Health Organization, United Kingdom. 2002. http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf . Accessed 7 Dec 2015.
2. Food and Drug Administration Amendments Act of 2007. 2007. http://www.fda.gov/RegulatoryInformation/Legislation/SignificantAmendmentstotheFDCAct/FoodandDrugAdministrationAmendmentsActof2007/FullTextofFDAAALaw/default.htm . Accessed 16 Sept 2015.
3. Patadia VK, Coloma P, Schuemie MJ, Herings R, Gini R, Mazzaglia G, et al. Using real-world healthcare data for PV signal detection—the experience of the EU-ADR project. Expert Rev Clin Pharmacol. 2015;8(1):95–102. doi: 10.1586/17512433.2015.992878 .
4. Trifiro G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, et al. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? J Intern Med. 2014;275(6):551–61. doi: 10.1111/joim.12159 .
5. Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153(9):600–6. doi: 10.7326/0003-4819-153-9-201011020-00010 .
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献